GI
LMAT icon

GAMMA Investing’s LeMaitre Vascular LMAT Stock Holding History

GAMMA Investing’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.1K Sell
793
-55
-6% -$5.64K ﹤0.01% 2014
2026
Q1 		$92.6K Buy
848
+121
+17% +$11.5K ﹤0.01% 1742
2025
Q4 		$59K Buy
727
+179
+33% +$15.4K ﹤0.01% 1957
2025
Q3 		$48K Sell
548
-58
-10% -$5.18K ﹤0.01% 2018
2025
Q2 		$50.3K Sell
606
-36
-6% -$3.01K ﹤0.01% 1944
2025
Q1 		$53.9K Sell
642
-68
-10% -$6.33K ﹤0.01% 1739
2024
Q4 		$65.4K Sell
710
-26
-4% -$2.5K 0.01% 1441
2024
Q3 		$68.4K Buy
736
+188
+34% +$16.3K 0.01% 1268
2024
Q2 		$45.1K Buy
548
+199
+57% +$14.6K 0.01% 1271
2024
Q1 		$23.2K Buy
349
+237
+212% +$14.6K ﹤0.01% 1544
2023
Q4 		$6.5K Buy
+112
New +$5.87K ﹤0.01% 2112

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GAMMA Investing's LMAT Position: Q2 2026 in Review

GAMMA Investing reduced its LeMaitre Vascular (LMAT) stake by 6.5% in Q2 2026, selling an estimated $5.64K and leaving 793 shares worth $76.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

GAMMA Investing first reported a position in LMAT in Q4 2023 and has held it in 11 quarters since. The position peaked at $92.6K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • GAMMA Investing held 793 shares of LeMaitre Vascular worth $76.1K as of Q2 2026.
  • GAMMA Investing sold 55 LeMaitre Vascular shares in Q2 2026, an estimated $5.64K.
  • LeMaitre Vascular made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2014 holding.
  • GAMMA Investing first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's LeMaitre Vascular position peaked at $92.6K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.